201. Australian Wildlife After Dark
3,856 results on '"Robinson, Bruce"'
Search Results
202. LIBRETTO-531: a phase III study of selpercatinib in multikinase inhibitor-naïve RET-mutant medullary thyroid cancer
203. The DOPPS Practice Monitor–Peritoneal Dialysis (DPM-PD): From Practice to Policy and Policy to Practice
204. Medical and Surgical Care of Patients With Mesothelioma and Their Relatives Carrying Germline BAP1 Mutations
205. Recovery Time, Quality of Life, and Mortality in Hemodialysis Patients: The Dialysis Outcomes and Practice Patterns Study (DOPPS)
206. The DOPPS Practice Monitor for US Dialysis Care: Potential Impact of Recent Guidelines and Regulatory Changes on Management of Mineral and Bone Disorder Among US Hemodialysis Patients
207. Transport modeling in performance assessments for the Yucca Mountain disposal system for spent nuclear fuel and high-level radioactive waste
208. Labour’s Second Life: From a Virtual Strike to Union Island
209. 2014 Annual report - WA div.
210. Adverse Gastrointestinal Events With Sodium Polystyrene Sulfonate Use in Patients on Maintenance Hemodialysis: An International Cohort Study.
211. Cybersolidarity: Internet-Based Campaigning and Trade Union Internationalism
212. The DOPPS Practice Monitor for US Dialysis Care: Update on Trends in Anemia Management 2 Years Into the Bundle
213. Association of Dialysate Bicarbonate Concentration With Mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS)
214. Cure Glomerulonephropathy Pathology Classification and Core Scoring Criteria, Reproducibility, and Clinicopathologic Correlations
215. Immunotherapeutic Approaches and Vaccination Strategies
216. A Retrospective Cohort Study with Validation of Predictors of Differentiated Thyroid Cancer Outcomes
217. The AI-Assisted Identification and Clinical Efficacy of Baricitinib in the Treatment of COVID-19
218. Prognostic significance of pleural effusion exhausted CD8+ T cell subsets in non-small cell lung cancer and mesothelioma.
219. Effectiveness and Tolerance of Renin-Angiotensin System Inhibitors With Aging in Chronic Kidney Disease
220. Selpercatinib Treatment of RET-Mutated Thyroid Cancers Is Associated With Gastrointestinal Adverse Effects
221. Cabozantinib versus placebo in patients with radioiodine-refractory differentiated thyroid cancer (DTC) who have progressed after prior VEGFR-Targeted yherapy: updated results from the phase 3 COSMIC-311 trial and prespecified subgroup analyses based on prior therapy
222. Effect of age on efficacy and safety of cabozantinib vs placebo in patients with radioiodine refractory (RAI-R)-differentiated thyroid cancer (DTC) with progression after VEGFR-targeted therapy: subgroup analysis from Phase 3 COSMIC 311 study
223. An investigation into possible sex differences in Association of Haemoglobin with survival among Haemodialysis patients in the J‐DOPPS cohort
224. MO496: Serum Urea Levels and Cardiovascular Disease in Patients With Chronic Kidney Disease
225. Mortality Trends After Transfer From Peritoneal Dialysis to Hemodialysis
226. A Randomized, Double-Blind Noninferiority Study to Evaluate the Efficacy of the Cabozantinib Tablet at 60 mg Per Day Compared with the Cabozantinib Capsule at 140 mg Per Day in Patients with Progressive, Metastatic Medullary Thyroid Cancer
227. MO900: Diuretic Prescription Patterns in Haemodialysis Patients: International Variation Reported in the Dopps
228. MO863: Electronic Patient Reported Outcome (EPRO) Collection in Dopps: Prospective Study Designed to Understand the Severity and Temporal Changes in Pruritus Symptoms in Hemodialysis Patients
229. MO901: Longitudinal Pruritus Assessment in Hemodialysis Patients: 1-Year Course of Symptoms and Associations With Clinical and Patient-Reported Outcomes
230. Impact of baseline tumor burden on overall survival in patients with radioiodine‐refractory differentiated thyroid cancer treated with lenvatinib in the SELECT global phase 3 trial
231. A residence-time-based transport approach for the groundwater pathway in performance assessment models
232. Submission by Ag Institute Australia (AIA) to ACARA on primary and secondary curricula with particular reference to agriculture and natural resource sciences
233. Availability and prioritisation of COVID-19 vaccines among patients with advanced chronic kidney disease and kidney failure during the height of the pandemic: a global survey by the International Society of Nephrology
234. Association between changes in quality of life and mortality in hemodialysis patients: results from the DOPPS
235. NRASQ61R Mutation-specific Immunohistochemistry Also Identifies the HRASQ61R Mutation in Medullary Thyroid Cancer and May Have a Role in Triaging Genetic Testing for MEN2
236. Urea levels and cardiovascular disease in patients with chronic kidney disease.
237. Patiromer utilization in patients with advanced chronic kidney disease under nephrology care in Germany.
238. A Case Report of Poor Response to Selpercatinib in the Presence of a 632_633 RET Deletion.
239. Improving Outcomes in Adrenocortical Cancer: An Australian Perspective
240. Discovery of new biomarkers for malignant mesothelioma
241. Assessment of the psychological burden associated with pruritus in hemodialysis patients using the kidney disease quality of life short form
242. Association of Biomarker Levels with Severity of Asbestos-Related Diseases
243. How Our Continuing Studies of the Pre-clinical Inbred Mouse Models of Mesothelioma Have Influenced the Development of New Therapies
244. Refractory Riedel’s thyroiditis managed with low dose radiotherapy
245. American Head and Neck Society Endocrine Surgery Section and International Thyroid Oncology Group consensus statement on mutational testing in thyroid cancer: Defining advanced thyroid cancer and its targeted treatment
246. Authors’ Reply
247. What’s next in cancer immunotherapy? - The promise and challenges of neoantigen vaccination
248. Potential Surrogate Outcomes for Kidney Failure in Advanced CKD: Evaluation of Power and Predictive Ability in CKDopps
249. Surveillance Improves Outcomes for Carriers of SDHB Pathogenic Variants: A Multicenter Study
250. Routinely measured cardiac troponin I and N‐terminal pro‐B‐type natriuretic peptide as predictors of mortality in haemodialysis patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.